AbbVie’s Tavapadon Shows Positive Results in Phase III TEMPO-2 Study for Parkinson’s Disease
US-based pharmaceutical company AbbVie (NYSE: ABBV) has revealed positive top-line results from the pivotal Phase...
Eli Lilly’s Jaypirca Demonstrates Superiority in BRUIN CLL-321 Study for CLL/SLL Treatment
US pharmaceutical major Eli Lilly and Company (NYSE: LLY) unveiled the latest data from the...
CDE Releases 89th Batch of Reference Preparations for Generic Quality Consistency
The Center for Drug Evaluation (CDE) in China has announced the selection of the 89th...
Jiangsu Hengrui Pharmaceuticals Plans Secondary Listing on Hong Kong Stock Exchange
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has confirmed reports regarding its intention to make...
Keymed Biosciences Presents CM336 Data for Relapsed Multiple Myeloma at ASH Annual Meeting
China-based Keymed Biosciences Inc., (HKG: 2162) has announced the presentation of the latest data from...
Antengene’s Xpovio Showcases Positive Results in Phase III BENCH and Phase I/II TOUCH Studies at ASH 2024
China-based Antengene Corporation Limited (Antengene, HKG: 6996) announced the presentation of the latest results from...
Lee’s Pharmaceutical Receives NMPA Approval for Generic Glaucoma Treatments
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) subsidiary, Zhaoke Ophthalmology Ltd (HKG: 6622), has announced...
NMPA Proposes Draft for Simplified Registration of Traditional Chinese Medicines from Hong Kong and Macao
The National Medical Products Administration (NMPA) has issued the “Notification on Simplifying the Registration and...
China’s NHSA and NHC Issue Guidelines to Enhance Volume-based Procurement Mechanism
The National Healthcare Security Administration (NHSA) and National Health Commission (NHC) of China have released...
CSPC Pharmaceutical Group’s SYHX2011 for Metastatic Breast Cancer Accepted for NMPA Review
China-based CSPC Pharmaceutical Group Co., Ltd. (HKG: 1093) has announced that the National Medical Products...
GSK’s Nucala Receives FDA Review for COPD Indication Based on MATINEE Study Data
UK-based pharmaceutical giant GSK (NYSE: GSK) has announced that the US Food and Drug Administration...
Hantech Medical Device Co., Ltd Acquires BD’s Villamarzana Factory to Expand Manufacturing
China-based Hantech Medical Device Co., Ltd, a Contract Development Manufacturing Organization (CDMO) specializing in medical...
Precision Biotech and T&L Biotechnology Form Partnership to Advance Cell and Gene Therapies
China-based Precision Biotech has announced a strategic partnership with compatriot firm T&L Biotechnology Co., Ltd....
MicroPort Scientific Corp. Launches FireFalcon Balloon for Coronary Interventions with NMPA Approval
Shanghai-based medical device giant MicroPort Scientific Corp., (HKG: 0853) has announced that it has received...
HuidaGene Therapeutics Initiates HERO Trial for RNA-Editing Therapy HG204 in MECP2 Duplication Syndrome
Shanghai-based HuidaGene Therapeutics has announced the first subject dosing of the HERO clinical trial, which...
Simcere Pharmaceutical’s SIM0508 Reaches First Patient Dosing in Global Clinical Study
China-based Simcere Pharmaceutical Group Limited’s (HKG: 2096) subsidiary, Simcere Zaiming, has announced the first patient...
Livzon Pharmaceutical Group Inks Influenza Vaccine Patent Deal with South China Vaccine Corporation
China-based Livzon Pharmaceutical Group Inc. (HKG: 1513) has entered into a significant patent and technology...
WuXi AppTec’s Subsidiary Invests EUR 20 Million in Jeito II S.L.P. for Growth Expansion
China-based Contract Development and Manufacturing Organization (CDMO) WuXi AppTec Co., Ltd (SHA: 603259) has announced...
TJ Biopharma and Jumpcan Pharmaceutical Announce NMPA Review of Eftansomatropin Alfa BLA
Chinese partners TJ Biopharma and Jumpcan Pharmaceutical (SHA: 600566) have jointly announced that the National...
AstraZeneca’s Imfinzi Receives FDA Priority Review for Muscle-Invasive Bladder Cancer
UK pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) has announced that the US Food and Drug...